Related Experiment Video
Updated: Aug 21, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
In-vitro activity of nitrofurantoin in enterococcus urinary tract infection
T Butt1, M J Leghari, A Mahmood
1Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi.
Objective:
To compare in-vitro antimicrobial susceptibility of nitrofurantoin against commonly used antimicrobials for the treatment of urinary tract infection caused by enterococci.
Methods:
A total of 144 enterococci (Enterococcus faecalis, n=130, Enterococcus faecium, n=14) isolated and confirmed by biochemical tests at the department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, for a period of three years were included in the study. The antimicrobial susceptibility tests of isolated organisms were performed by standard disc diffusion method as recommended by NCCLS. In addition to nitrofurantoin (NIT), doxycycline (DOX), co-trimoxazole (COT), ampicillin (AMP), imipenem (IPM) and vancomycin (VAN) were used for antimicrobial susceptibility testing.
Results:
One hundred and twenty seven (88%) isolates of Enterococci were susceptible to NIT while 72% (n = 103) to AMP, 13% to COT, 11% to DOX, 91% to IPM and 99% to VAN. Among the strains resistant to AMP, COT, DOX, IPM and VAN, 50-88% were susceptible to NIT.
Conclusion:
Nitrofurantoin is an effective antimicrobial in vitro and can be used for treatment of Enterococcus urinary tract infections.
Insights
Nitrofurantoin shows high in-vitro antimicrobial susceptibility against Enterococcus species, a common cause of urinary tract infections. This makes nitrofurantoin a viable treatment option for enterococcal UTIs.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Enterococci are a significant cause of urinary tract infections (UTIs).
- Antimicrobial resistance in enterococci necessitates evaluating effective treatment options.
Purpose of the Study:
- To compare the in-vitro antimicrobial susceptibility of nitrofurantoin against other commonly used antimicrobials for treating enterococcal UTIs.
Main Methods:
- 144 enterococcal isolates (Enterococcus faecalis and Enterococcus faecium) were tested.
- Standard disc diffusion method was used for antimicrobial susceptibility testing.
- Nitrofurantoin, doxycycline, co-trimoxazole, ampicillin, imipenem, and vancomycin were evaluated.
Main Results:
- Nitrofurantoin demonstrated high susceptibility (88%) against enterococcal isolates.
- While vancomycin (99%) and imipenem (91%) showed higher susceptibility, nitrofurantoin was effective against strains resistant to other antibiotics.
- Susceptibility to ampicillin, co-trimoxazole, and doxycycline was lower (72%, 13%, 11% respectively).
Conclusions:
- Nitrofurantoin is an effective antimicrobial agent in vitro for treating Enterococcus UTIs.
- Its efficacy, particularly against resistant strains, supports its use in clinical practice.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Microbiota of the Urogenital Tract
Urinary Tract Infection I: Introduction
Inhibitors of Bacterial DNA Synthesis
